Covid-19 Products Scheme

Description

General:
The scheme is open to COVID-19 relevant product activities only.
Retrospective costs (on or after the 1st February 2020): Where applicable, costs associated with activities of qualifying projects may be retrospectively funded. In these cases, the aid must assist projects which accelerate project implementation or extend project scope. The company must demonstrate to the satisfaction of Enterprise Ireland that costs were incurred on or after the 1st of February 2020.
Funding must be approved by Enterprise Ireland no later than the 15th of December 2020. The cut-off date for applications in line with the lifespan of the Scheme is the 30th November 2020.

Covid-19 Products Scheme

The COVID-19 outbreak has resulted in an urgent need across the EU and globally for medical and public health R&D, products and solutions. In response, The EU Temporary State Aid Framework has been amended to allow for, “the facilitation of research and development and expanded production into Coronavirus related products”.

The COVID-19 Products Scheme is composed of three measures, all of which aim to support Irish based internationally focused companies (SME and Large) to address:

  • Measure 1: COVID-19 relevant research and development (“R&D”) activities by companies coupled with the creation of useful IP.
  • Measure 2: The construction and upgrade of testing and upscaling infrastructures that are utilised to develop COVID-19 relevant products.
  • Measure 3: Increased production of products needed to respond to the COVID-19 outbreak. These outputs should be achieved as quickly as possible.

The scheme is time-limited and all funding must be approved by Enterprise Ireland no later than the 15th of December 2020. The scheme is now open for applications.

What are COVID-19 relevant products?

  • Relevant medicinal products (including vaccines) and treatments and their intermediates, active pharmaceutical ingredients and raw materials.
  • Medical devices and hospital and medical equipment, including PPE and necessary raw materials.
  • Disinfectants and their intermediary products and raw chemical materials necessary for their production.
  • Track and trace, temperature monitoring and relevant COVID-19 responsive services.
  • Process innovations targeting an efficient and streamlined production of the above.

Description of funding

This is a budget-limited scheme with the following features:

Measure 1

  • Max Grant Rate: up to 50% of qualifying costs
  • Max Grant: €650,000 per project

Measure 2 & 3

  • Max Grant Rate: up to 50% of qualifying costs
  • There is no upper limit to overall grant size (subject to budget)

Companies may make applications to all measures concurrently.

Listing Details

Instagram:
LinkedIn:
Twitter:
Delivery Radius:
Interest Rate:
Value: Measure 1 Max Grant Rate: up to 50% of qualifying costs Max Grant: ?650,000 per project Measure 2 & 3 Max Grant Rate: up to 50% of qualifying costs There is no upper limit to overall grant size (subject to budget)
Facebook:
Term:
Scroll to Top
X
X
X
X
X